Gasgon SIGNED
Development of a Novel Medical Device to Remove Air Bubbles from Medicines, Which Will Improve Patient Safety and Reduce Costs of IV Infusion
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0Gasgon project word cloud
Explore the words cloud of the Gasgon project. It provides you a very rough idea of what is the project "Gasgon" about.
Project "Gasgon" data sheet
The following table provides information about the project.
| Coordinator |
TESSEN SOLUTIONS LIMITED
Organization address contact info |
| Coordinator Country | Ireland [IE] |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-1 |
| Funding Scheme | SME-1 |
| Starting year | 2020 |
| Duration (year-month-day) | from 2020-01-01 to 2020-06-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | TESSEN SOLUTIONS LIMITED | IE (Cork) | coordinator | 50˙000.00 |
Map
Project objective
Over 2 billion medical intravenous (IV) infusions occur each year globally, with over 80% of inpatients receiving IV treatment. Each of these infusions carry a serious health risk – the risk that gas bubbles enter with the fluid and block blood flow in patients. Air Embolism, a potentially deadly complication of IV infusion, is a result of bubbles entering the venous system and blocking blood flow leading to serious adverse complications for patients such as Sepsis, Stroke, Brain Dysfunction and Heart Attack. In extreme cases death can occur. Gasgon Medical has built a break-through and disruptive technology to reduce risk and optimise fluid management in common medical IV treatments. Currently clinicians must intervene to remove every bubble in every infusion, a labour-intensive practice that puts a strain on healthcare resources, with wasted man-hours and reduced efficacy of the medicine dose. Technology solutions on the market include electronic alarms and in-line filters – these are unsuitable in the majority of cases and place a significant human and financial burden on healthcare providers. Our innovation, which is a new form of ‘vent’ technology, will solve this unmet clinical need. Gasgon Medical has invented the first mechanical, in-line, automatic vent capable of removing bubbles from IV fluids regardless of position or environment. Our Patent-pending disposable vent acts quickly and reliably without interrupting or reducing the prescribed dose of medications. This represents a major technology advancement over current methods of managing risk in IV infusions. Gasgon Medical can lead a €220mn IV vent opportunity bringing an exciting European innovation to the global market. This novel Gasgon vent technology has the potential to positively impact healthcare delivery and performance, leading to better patient outcomes.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GASGON" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "GASGON" are provided by the European Opendata Portal: CORDIS opendata.